We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.56%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.3B
AUM Growth
+$580M
(+2.8%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
35.94%
Holding
882
New
52
Increased
484
Reduced
289
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGD
New Gold Inc
NGD
|
+$52.1M |
| 2 |
Veeva Systems
VEEV
|
+$37.6M |
| 3 |
UnitedHealth
UNH
|
+$36.1M |
| 4 |
ServiceNow
NOW
|
+$35.9M |
| 5 |
B
Barrick Mining
B
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$43.4M |
| 2 |
ESV
Ensco Rowan plc
ESV
|
+$38.4M |
| 3 |
Walt Disney
DIS
|
+$35.1M |
| 4 |
McKesson
MCK
|
+$34.8M |
| 5 |
Hershey
HSY
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 56.36% |
| 2 | Technology | 9.22% |
| 3 | Energy | 7.08% |
| 4 | Healthcare | 5.95% |
| 5 | Financials | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Elanco Animal Health
ELAN
$12.7B
| $16.8M | 0.08% |
633,280
-30,632
| -5% | -$919K |
|
|
INVX
177
Innovex International
INVX
$1.85B
| $16.7M | 0.08% |
332,490
-192,752
| -37% | -$9.41M |
|
178
IQVIA
IQV
$35.6B
| $16.5M | 0.08% |
110,686
-15,506
| -12% | -$2.41M |
|
|
NEE.PRO
179
DELISTED
NextEra Energy, Inc. 4.872% Corporate Units
NEE.PRO
| $16.4M | 0.08% |
+327,714
| New | +$16.1M |
|
180
Oceaneering
OII
$5.19B
| $16.2M | 0.08% |
1,197,514
-603,012
| -33% | -$9.14M |
|
181
Simon Property Group
SPG
$75.1B
| $16.2M | 0.08% |
104,055
+3,327
| +3% | +$517K |
|
182
Home Depot
HD
$335B
| $15.8M | 0.07% |
68,098
+927
| +1% | +$203K |
|
183
Helix Energy Solutions
HLX
$1.42B
| $14.8M | 0.07% |
+1,831,834
| New | +$14.8M |
|
184
FMC
FMC
$1.39B
| $14.7M | 0.07% |
167,286
-16,407
| -9% | -$1.41M |
|
185
Regeneron Pharmaceuticals
REGN
$69.9B
| $14.5M | 0.07% |
52,427
+816
| +2% | +$241K |
|
186
Prospect Capital
PSEC
$1.12B
| $14.2M | 0.07% |
2,158,164
+63,454
| +3% | +$418K |
|
187
Incyte
INCY
$23.7B
| $14.1M | 0.07% |
189,272
-19,183
| -9% | -$1.55M |
|
188
Starwood Property Trust
STWD
$6.15B
| $13.9M | 0.07% |
573,681
+58,134
| +11% | +$1.37M |
|
189
ON Semiconductor
ON
$34.7B
| $13.5M | 0.06% |
704,870
+135,805
| +24% | +$2.61M |
|
|
ALXN
190
DELISTED
Alexion Pharmaceuticals
ALXN
| $13.4M | 0.06% |
136,402
+5,437
| +4% | +$613K |
|
|
GPL
191
DELISTED
Great Panther Mining Limited
GPL
| $13.3M | 0.06% |
1,885,681
+77,332
| +4% | +$619K |
|
192
Universal Display
OLED
$3.81B
| $13.2M | 0.06% |
78,549
+8,240
| +12% | +$1.65M |
|
193
DuPont de Nemours
DD
$18.9B
| $13.1M | 0.06% |
145,835
-5,234
| -3% | -$461K |
|
194
AbbVie
ABBV
$454B
| $12.9M | 0.06% |
170,691
-3,466
| -2% | -$238K |
|
195
Prologis
PLD
$137B
| $12.9M | 0.06% |
151,073
+4,972
| +3% | +$411K |
|
196
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.66B
| $12.8M | 0.06% |
766,704
-3,553
| -0.5% | -$58.3K |
|
197
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.35B
| $12.8M | 0.06% |
893,410
+14,714
| +2% | +$209K |
|
198
Nuveen Quality Municipal Income Fund
NAD
$2.72B
| $12.8M | 0.06% |
888,412
+16,674
| +2% | +$239K |
|
199
Rithm Capital
RITM
$5.15B
| $12.5M | 0.06% |
797,041
+14,966
| +2% | +$224K |
|
|
EXAS
200
DELISTED
Exact Sciences
EXAS
| $12.4M | 0.06% |
136,778
-3,950
| -3% | -$450K |
|
Similar funds
DAM
VanEck Associates's Q3 2019 Portfolio in Review
As of Q3 2019, VanEck Associates held 882 positions worth $21.3B, up 2.8% from $20.8B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
VanEck Associates's Q3 2019 filing shows 52 new, 484 increased, 289 reduced and 51 closed positions. Its largest new stake was Veeva Systems: 234,351 shares worth $35.8M. The largest sale was Allergan plc, an estimated $43.4M.
By sector, the portfolio is most concentrated in Materials at 56% of assets, up from 55% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2019 buy was Veeva Systems: 234,351 shares worth $35.8M.
- VanEck Associates added most to New Gold Inc in Q3 2019, an estimated $52.1M increase.
- VanEck Associates's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $43.4M.
- VanEck Associates fully exited Ensco Rowan plc in Q3 2019, selling an estimated $38.4M.
- VanEck Associates's ten largest holdings make up 36% of its $21.3B portfolio in Q3 2019.
- VanEck Associates opened 52 new positions and closed 51 in Q3 2019.
- VanEck Associates's portfolio value rose 2.8% quarter-over-quarter to $21.3B.
Based on VanEck Associates's 13F filing for Q3 2019, filed 8 Nov 2019.